Wagner Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Wagner Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $302 - $178,729	-2,326 Reduced 97.2%	67 $5,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $173,779 - $191,392	2,393 New	2,393 $184,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $151,486 - $181,646	-2,464 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $16,518 - $19,256	-308 Reduced 11.11%	2,464 $154,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $16,745 - $19,614	-283 Reduced 9.26%	2,772 $162,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $27,240 - $29,664	440 Added 16.83%	3,055 $204,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $155,174 - $174,525	2,615 New	2,615 $165,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $80,836 - $91,602	-1,400 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$50.53 - $62.98 $17,533 - $21,854	347 Added 32.95%	1,400 $77,000
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $22,170 - $25,522	370 Added 54.17%	1,053 $67,000
Q4 2017 Feb 22, 2018	BUY	$59.94 - $65.35 $40,939 - $44,634	683	683 $43,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.